2008Unpublished venueRequires access

Progresses of diagnosis and therapy in methylmalonic acidemia

Wang Fei

Open publisher page 0 citations

Abstract

Methylmalonic acidemia is an organic acidemia with autosomal recessive heredity,of which the cli- nical presentations are heterogeneous. It is characterized by recurrent vomiting and the neurological symptoms such as lethargy,convulsion,and so on. Diagnosis of this disease depends on the measurement of acylcarnitines in the blood by tandem mass spectrometry and the detection of methylmalonic acid in the urine by gas-chromatography mass spectrometry. The patients with methylmalonic acidemia and homocystinuria should be mainly treated with vitamin B12,betaine and L-carnitine,while the patients with isolated methymalonic acidemia should be treated with protein restriction,the special milk formula without isoleucine,valine,methionine and threonine,as well as the L-carnitine. Compared with the vitamin B_(12)-nonresponsive patients,the vitamin B_(12)-responsive ones have better outcome.

About this research paper

What this paper is about

Methylmalonic acidemia is an organic acidemia with autosomal recessive heredity,of which the cli- nical presentations are heterogeneous. It is characterized by recurrent vomiting and the neurological symptoms such as lethargy,convulsion,and so on. Diagnosis of this disease depends on the measurement of acylcarnitines in the blood by tandem mass spectrometry and the detection of methylmalonic acid in the urine by gas-chromatography mass spectrometry. The patients with methylmalonic acidemia and homocystinuria should be mainly treated with vitamin B12,betaine and L-carnitine,while the patients with isolated methymalonic acidemia should be treated with protein restriction,the special milk formula without isoleucine,valine,methionine and threonine,as well as the L-carnitine. Compared with the vitamin B_(12)-nonresponsive patients,the vitamin B_(12)-responsive ones have better outcome.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Methylmalonic acidemia is an organic acidemia with autosomal recessive heredity,of which the cli- nical presentations are heterogeneous. It is characterized by recurrent vomiting and the neurological symptoms such as lethargy,convulsion,and so on. Diagnosis of this disease depends on the measurement of acylcarnitines in the blood by tandem mass spectrometry and the detection of methylmalonic acid in the urine by gas-chromatography mass spectrometry. The patients with methylmalonic acidemia and homocystinuria should be mainly treated with vitamin B12,betaine and L-carnitine,while the patients with isolated methymalonic acidemia should be treated with protein restriction,the special milk formula without isoleucine,valine,methionine and threonine,as well as the L-carnitine. Compared with the vitamin B_(12)-nonresponsive patients,the vitamin B_(12)-responsive ones have better outcome.

Key concepts: Methylmalonic acidemia, Methylmalonic acid, Propionic acidemia, Lethargy, Methylmalonic aciduria, Homocystinuria, Carnitine, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Progresses of diagnosis and therapy in methylmalonic acidemia — Research Paper | ScholarLens